Save
SSC on the Case: Procoagulant Platelets: From Bench to Bedside
ISTH Academy, Faculty / Presenters, 412029
SSC on the Case: Pediatric and Neonatal Thrombosis and Hemostasis: Post-Liver Transplantation Factor VII Deficiency
ISTH Academy, Faculty / Presenters, 410016
Short Promotional Clip - DOACs and Cancer: Assessing Important Drug-Drug Interactions
ISTH Academy, Faculty / Presenters, 412610
DOACs and Cancer: Assessing Important Drug-Drug Interactions
ISTH Academy, Faculty / Presenters, 410898
How to Deliver a Successful Oral Presentation
ISTH Academy, Faculty / Presenters, 411786
Plasma from patients with vaccine-induced immune thrombotic thrombocytopenia displays increased fibrinolytic potential and enhances tissue-type plasminogen activator but not urokinase-mediated plasminogen activation
ISTH Academy, Huyen Tran, 411334
Management of catheter-related upper extremity deep vein thrombosis in patients with cancer: a systematic review and meta-analysis
ISTH Academy, , 411331
Annoucement
ISTH Academy, Faculty / Presenters, 411349
Ellinor Peerschke, PhD (1954-2023)
ISTH Academy, Faculty / Presenters, 411348
“Guidance on the Critical Shortage of Sodium Citrate Coagulation Tubes for Hemostasis Testing”: comment from Radišić Biljak et al.
ISTH Academy, Faculty / Presenters, 411347
“The portal vein in patients with cirrhosis is not an excessively inflammatory or hypercoagulable vascular bed, a prospective cohort study”: reply
ISTH Academy, Ton Lisman, 411346
“The portal vein in patients with cirrhosis is not an excessively inflammatory or hypercoagulable vascular bed, a prospective cohort study”: comment from Liu et al.
ISTH Academy, , 411345
“Women with severe postpartum hemorrhage have a decreased endogenous thrombin potential before delivery”: reply
ISTH Academy, Faculty / Presenters, 411344
“Women with severe postpartum hemorrhage have a decreased endogenous thrombin potential before delivery”: Comment from Mishima et al.
ISTH Academy, Kenichi Tanaka, 411343
Antiphospholipid antibody solid phase–based assays: problems and proposed solutions for the 2023 ACR/EULAR classification criteria for antiphospholipid syndrome
ISTH Academy, Faculty / Presenters, 411342
SERPINH1 variants and thrombotic risk among middle-aged and older adults: a population-based cohort study
ISTH Academy, Bengt Zöller, 411341
Diagnostic value of antibody-induced procoagulant platelets in heparin-induced thrombocytopenia: communication from the ISTH SSC Subcommittee on Platelet Immunology
ISTH Academy, Tamam Bakchoul, 411340
Targeted long-read sequencing identifies and characterizes structural variants in cases of inherited platelet disorders
ISTH Academy, Faculty / Presenters, 411339
Deficiency of thioredoxin-interacting protein results in age-related thrombocytopenia due to megakaryocyte oxidative stress
ISTH Academy, , 411338
Inhibition of cellular activation induced by platelet factor 4 via the CXCR3 pathway ameliorates Japanese encephalitis and dengue viral infections
ISTH Academy, , 411337
Genetic and nongenetic drivers of platelet reactivity in healthy Tanzanian individuals
ISTH Academy, Quirijn de Mast, 411336
Synergism of red blood cells and tranexamic acid in the inhibition of fibrinolysis
ISTH Academy, , 411335
What is in it for the reviewer?
ISTH Academy, Faculty / Presenters, 411314
The risk for venous thromboembolism and cardiometabolic disorders in offspring from thrombosis-prone pedigrees
ISTH Academy, Faculty / Presenters, 411333
Association of pharmacologic thromboprophylaxis with clinically relevant bleeding and hospital-acquired anemia in medical inpatients: the risk stratification for hospital-acquired venous thromboembolism in medical patients study
ISTH Academy, Faculty / Presenters, 411332
Issue Information
ISTH Academy, Faculty / Presenters, 411313
Proteomic insights into modifiable risk of venous thromboembolism and cardiovascular comorbidities
ISTH Academy, , 411330
Periprocedural management of direct oral anticoagulants in patients with atrial fibrillation and active cancer
ISTH Academy, Faculty / Presenters, 411329
Interplay of fibrinogen αC globular domains and factor XIIIa cross-linking dictates the extensibility and strain stiffening of fibrin networks
ISTH Academy, Gijsje Koenderink, 411328
Structural architecture of the acidic region of the B domain of coagulation factor V
ISTH Academy, Enrico Di Cera, 411327
Extravascular factor IX pool fed by prophylaxis is a true hemostatic barrier against bleeding
ISTH Academy, Yesim Dargaud, 411326
Mechanisms of action of an investigational new freeze-dried platelet-derived hemostatic product
ISTH Academy, Faculty / Presenters, 411325
Group B or not group B? An association between ABO, early mortality, and organ dysfunction in major trauma patients with shock
ISTH Academy, Faculty / Presenters, 411324
The common VWF variant p.Y1584C: detailed pathogenic examination of an enigmatic sequence change
ISTH Academy, David Lillicrap, 411323
Evaluating the clinical validity of genes related to hemostasis and thrombosis using the Clinical Genome Resource gene curation framework
ISTH Academy, Michele Lambert, 411322
Humanization and functional characterization of enhanced coagulation factor IX variants identified through ancestral sequence reconstruction
ISTH Academy, Chris Doering, 411321
Coagulation factor XIII is a critical driver of liver regeneration after partial hepatectomy
ISTH Academy, James Luyendyk, 411320
Dissecting the rationale for thromboprophylaxis in challenging surgical cases
ISTH Academy, Faculty / Presenters, 411319
Commentary on “Inhibition of cellular activation induced by platelet factor 4 via the CXCR3 pathway ameliorates Japanese encephalitis and dengue viral infections”
ISTH Academy, , 411318
D-dimer Levels for the exclusion of pulmonary embolism: making sense of international guideline recommendations
ISTH Academy, Emmanuel Favaloro, 411317
Between a rock and a hard place: resumption of oral anticoagulant therapy after intracranial hemorrhage
ISTH Academy, Faculty / Presenters, 411316
When to use tranexamic acid for the treatment of major bleeding?
ISTH Academy, Faculty / Presenters, 411315
TPO Mimetics for Thrombocytopenia and Thrombosis Risk
ISTH Academy, Faculty / Presenters, 409978
Short - TPO Mimetics for Thrombocytopenia and Thrombosis Risk Preview Clip
ISTH Academy, Faculty / Presenters, 411241
Association between severity of pulmonary embolism and health-related quality of life
ISTH Academy, Faculty / Presenters, 410501
Incidence of venous thromboembolism, recurrence, and bleeding after isolated superficial vein thrombosis: findings from the Venous Thrombosis Registry in Østfold Hospital
ISTH Academy, Faculty / Presenters, 410502
Efficacy and safety of direct oral anticoagulants in splanchnic vein thrombosis: a pooled analysis of literature studies
ISTH Academy, Matteo Di Minno, 410503
Racial and ethnic disparities in eligibility for postpartum venous thromboembolism prophylaxis in the United States
ISTH Academy, , 410504
Antiplatelet drugs do not protect from platelet-leukocyte aggregation in coronary artery disease
ISTH Academy, , 410505
A novel leukocyte adhesion deficiency type III mutation manifests functional importance of the compact FERM domain in kindlin-3
ISTH Academy, Jordan Shavit, 410506
Uncertainties about the roles of anticoagulation and microclots in postacute sequelae of SARS-CoV-2 infection: comment from Kell et al.
ISTH Academy, , 410507
Uncertainties about the roles of anticoagulation and microclots in post-acute sequelae of SARS-CoV-2 infection—response to the letter by Kell et al.
ISTH Academy, , 410508
“Defining Heparin Resistance: Communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis”: comment from Gouin-Thibault et al.
ISTH Academy, Faculty / Presenters, 410509
Reply to the letter to the editor regarding “Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis”
ISTH Academy, Faculty / Presenters, 410510
ISTH News and Updates: Join the ISTH Today
ISTH Academy, Faculty / Presenters, 410511
Development and validation of a risk model for hospital-acquired venous thrombosis: the Medical Inpatients Thrombosis and Hemostasis study
ISTH Academy, Faculty / Presenters, 410500
Open ADAMTS-13 conformation index predicts earlier relapse in immune-mediated thrombotic thrombocytopenic purpura
ISTH Academy, Karen Vanhoorelbeke, 410499
Whole blood thrombin generation shows a significant hypocoagulable state in patients with decompensated cirrhosis
ISTH Academy, Paolo Simioni, 410498
Heparin-activated procoagulant platelet assay: a flow cytometry-based functional test for heparin-induced thrombocytopenia
ISTH Academy, Faculty / Presenters, 410497
Late-onset vitamin K deficiency bleeding in an extremely preterm infant fed an exclusively human milk–based diet
ISTH Academy, Faculty / Presenters, 410496
Alterations in the von Willebrand factor/ADAMTS-13 axis in preeclampsia
ISTH Academy, Faculty / Presenters, 410495
MicroRNA-10a enrichment in factor VIIa–released endothelial extracellular vesicles: potential mechanisms
ISTH Academy, Vijay Rao, 410494
A bispecific antibody NXT007 exerts a hemostatic activity in hemophilia A monkeys enough to keep a nonhemophilic state
ISTH Academy, Faculty / Presenters, 410493
Comparison of direct oral anticoagulants versus low-molecular-weight heparin in primary and metastatic brain cancers: a meta-analysis and systematic review
ISTH Academy, Rushad Patell, 410492
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency
ISTH Academy, Elisabetta Castoldi, 410491
Glycolytic reprogramming fuels myeloid cell-driven hypercoagulability
ISTH Academy, Roger Preston, 410490
Heterozygosity in factor XIII genes and the manifestation of mild inherited factor XIII deficiency
ISTH Academy, Arijit Biswas, 410489
Clinical care of pediatric patients with or at risk of postthrombotic syndrome: guidance from the ISTH SSC Subcommittee on pediatric and neonatal thrombosis and hemostasis
ISTH Academy, Ayesha Zia, 410488
Postpulmonary embolism syndrome: what should we focus on?
ISTH Academy, , 410487
From coagulation to calm: factor VIIa’s microRNA magic trick
ISTH Academy, Erica Sparkenbaugh, 410486
Thrombin generation in cirrhosis: whole blood, whole truth?
ISTH Academy, Mattias Mandorfer, 410485
Hemophilia A treatment innovation: factor VIII mimetic bispecific antibodies—generational enhancement
ISTH Academy, Faculty / Presenters, 410484
Trauma-induced innate immune activation and disseminated intravascular coagulation
ISTH Academy, Faculty / Presenters, 410483
Anticoagulation in chronic kidney disease: current status and future perspectives
ISTH Academy, Faculty / Presenters, 410482
What do we know about why women bleed and what do we not know?
ISTH Academy, Faculty / Presenters, 410481
Finding a fountain of youth in the blood
ISTH Academy, Robert Campbell, 410480
Importance of early career professionals in the SSC of the ISTH
ISTH Academy, Faculty / Presenters, 410479
Issue Information
ISTH Academy, Faculty / Presenters, 410478
Microfluidics Devices in Hemostasis / Point-of-care Testing
ISTH Academy, Faculty / Presenters, 408333
ISTH News and Updates: Join the ISTH Today
ISTH Academy, Faculty / Presenters, 409392
Evaluation of laboratory testing parameters for vaccine-induced immune thrombotic thrombocytopenia and their implications for diagnosis
ISTH Academy, Ishac Nazy, 409391
Reversal of factor XI targeting anticoagulants: an in vitro evaluation
ISTH Academy, Joost Meijers, 409390
COVID-19 promotes endothelial dysfunction and thrombogenicity: role of proinflammatory cytokines/SGLT2 prooxidant pathway
ISTH Academy, , 409389
Trivalent nanobody-based ligands mediate powerful activation of GPVI, CLEC-2, and PEAR1 in human platelets whereas FcγRIIA requires a tetravalent ligand
ISTH Academy, Steve Watson, 409388
Thrombin-activatable fibrinolysis inhibitor and sex modulate thrombus stability and pulmonary embolism burden in a murine model
ISTH Academy, Paul Kim, 409387
Availability of medical and endovascular therapies for venous thromboembolism: a global survey for World Thrombosis Day
ISTH Academy, Stefano Barco, 409386
Development and validation of a clinical prediction model for 90-day venous thromboembolism risk following total hip and total knee arthroplasty: a multinational study
ISTH Academy, , 409384
High molecular weight kininogen interactions with the homologs prekallikrein and factor XI: importance to surface-induced coagulation
ISTH Academy, David Gailani, 409383
Effect of factor XI inhibition on tumor cell-induced coagulation activation
ISTH Academy, Florian Langer, 409381
Neutrophil extracellular traps induce persistent lung tissue damage via thromboinflammation without altering virus resolution in a mouse coronavirus model
ISTH Academy, Philipp Hohensinner, 409380
Platelets and neutrophils cooperate to induce increased neutrophil extracellular trap formation in JAK2V617F myeloproliferative neoplasms
ISTH Academy, Chloé James, 409379
Functional capacity and dyspnea during follow-up after acute pulmonary embolism
ISTH Academy, Stavros Konstantinides, 409378
Patients with moderate hemophilia A and B with a severe bleeding phenotype have an increased burden of disease
ISTH Academy, Saskia Schols, 409377
Doing more with less: low-titer group O whole blood resulted in less total transfusions and an independent association with survival in adults with severe traumatic hemorrhage
ISTH Academy, Faculty / Presenters, 409376
Desmopressin to prevent and treat bleeding in pregnant women with an inherited bleeding disorder: a systematic literature review
ISTH Academy, Faculty / Presenters, 409375
Thrombin generation on vascular cells in the presence of factor VIII and/or emicizumab
ISTH Academy, Faculty / Presenters, 409374
The necessity of repeat testing for von Willebrand disease in adult patients with mild to moderate bleeding disorders
ISTH Academy, Johanna Gebhart, 409373
COVID-19 outcomes in persons with hemophilia: results from a US-based national COVID-19 surveillance registry
ISTH Academy, Faculty / Presenters, 409370
Management of chemotherapy-induced thrombocytopenia: guidance from the ISTH Subcommittee on Hemostasis and Malignancy
ISTH Academy, , 409369
Decoding thrombosis through code: a review of computational models
ISTH Academy, David Bark, 409366

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings